Literature DB >> 9234041

Stages and processes of change as predictors of drug use among methadone maintenance patients.

M A Belding1, M Y Iguchi, R J Lamb.   

Abstract

In this study the authors evaluated the predictive validity of stages-of-change and processes-of- change measures among methadone maintenance patients. One month after treatment entry, participants completed questionnaires providing stage and process scale scores regarding readiness to discontinue polydrug use. Participants also completed an algorithm assigning them to a stage category on the basis of their stated intentions regarding quitting. The algorithm predicted urinalysis results during a 12-week posttest period; however, only 1 stage scale (contemplation) and no process scales correlated significantly with outcome. In a hierarchical regression, stage and process scale scores significantly improved prediction of posttest abstinence beyond that afforded by baseline drug-free urine rates, but this effect was attributable to the contemplation scale alone. Despite their widespread use, stage and process scales have yet to demonstrate clearly predictive validity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234041     DOI: 10.1037//1064-1297.5.1.65

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  3 in total

1.  Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status.

Authors:  Allison J Applebaum; Jacqueline R Bullis; Lara N Traeger; Conall O'cleirigh; Michael W Otto; Mark H Pollack; Steven A Safren
Journal:  Neurobehav HIV Med       Date:  2010-08-10

2.  Construct, concurrent and predictive validity of the URICA: data from two multi-site clinical trials.

Authors:  Craig A Field; Bryon Adinoff; T Robert Harris; Samuel A Ball; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2009-01-20       Impact factor: 4.492

3.  Stage-of-change Assessment Predicts Short-term Treatment Engagement for Opioid Use Disorder Patients Initiated on Buprenorphine.

Authors:  Quentin Reuter; Gregory L Larkin; Michael Dubé; Suman Vellanki; Amanda Dos Santos; Jamie McKinnon; Nicholas Jouriles; David Seaberg
Journal:  West J Emerg Med       Date:  2022-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.